Particle Therapy 2017

• …….

Particle beam therapy for patients with lung , breast, and prostate

cancer:

Compare the use of particle beam radiation therapy with

other forms of radiation therapies in patients with lung, breast, or

prostate cancer. Short- and long-term outcomes of interest might

include tumor site–specific toxicities, severity of adverse effects,

cancer-specific and overall mortality, quality of life, and functional

outcomes.

IV. Appendix: Research Topics of Interest to PCORI

PCORI was authorized by the Patient Protection and Affordable

Care Act of 2010 as a nonprofit, nongovernmental organization.

PCORI seeks to fund pragmatic clinical trials (PCTs), large simple trials (LSTs),

or large-scale observational studies that compare two or more alternatives for

addressing prevention, diagnosis, treatment, or management of a disease or

symptom;

Funding Cycle – start 2015:

Maximum Project Budget (Direct Costs) $10 million

Maximum Budget $ 90 million

Patient Centered Outcomes

Research Institut